Global Pen Needles Market Size By Type (Standard Pen Needles, Safety Pen Needles), By Therapy (Insulin, Glucagon-like Peptide-1 (GLP-1), Growth Hormone), By Application (Diabetes, Hormonal Disorders), By Geographic Scope And Forecast

Pen Needles Market Size And Forecast

Pen Needles Market size was valued at USD 3.14 Billion in the year 2024 and it is expected to reach USD 6.85 Billion in 2031, at a CAGR of 11.30% over the forecast period of 2024 to 2031.

Pen needles are essential, disposable devices used with insulin pens to administer insulin in diabetic patients. These small needles are designed to simplify the injection process, offering a convenient, efficient, and less painful method for managing diabetes.

Typically featuring a fine, short, and thin design, pen needles aim to minimize discomfort during injections while ensuring precise and consistent dosage delivery. This user-friendly approach has revolutionized diabetes care, allowing individuals to self-administer insulin with ease and discretion.

Pen needles come in various lengths and gauges, enabling users to select a size that best suits their comfort and injection preferences. This customization makes it easier for patients to adhere to their insulin regimens, promoting better health outcomes.

The innovation of pen needles has significantly improved the quality of life for those managing diabetes, offering a more manageable and less intimidating alternative to traditional vial-and-syringe methods.

In addition to insulin delivery, pen needles are used for administering other injectable medications, serving as a modern medication delivery system. The hollow needle, encased in a plastic hub, is attached to an injection pen that allows for quick and precise medication delivery.

Global Pen Needles Market Dynamics

The key market dynamics that are shaping the global pen needles market include:

Key Market Drivers

Rising Prevalence of Chronic Diseases Requiring Injectable Medications: Serious diseases have been far more common than they were a few years ago. These conditions, which include osteoporosis, multiple sclerosis, diabetes, and cardiovascular disease (CVD), necessitate the weekly or daily administration of medications, often administered using injectors. According to the International Diabetes Federation (IDF), the number of adults living with diabetes worldwide was estimated to be 463 million in 2019, and this number is projected to rise to 700 million by 2045, representing a 51% increase.

Growing Adoption of Self-Administration Practices: The trend towards home healthcare and self-administration of medications is driving the demand for pen needles, as they offer a convenient and less painful option for patients. A study published in the Journal of Diabetes Science and Technology found that 77% of patients preferred pen devices over vial and syringe methods for insulin administration, citing ease of use and reduced pain as primary factors.

Technological Advancements in Pen Needle Design: Innovations in pen needle technology, such as shorter and thinner needles, are improving patient comfort and driving market growth. According to a report by the U.S. Food and Drug Administration (FDA), the use of shorter needles (4mm to 5mm) for insulin injection has increased from less than 5% in 2010 to over 30% in 2020, indicating a significant shift towards more patient-friendly designs.

Key Trends

Risk of Complications and Side Effects: Pen needles are a simple and convenient way to administer medication, but they can also result in discomfort, hyperglycemia, needlestick wounds, and infections. A study published in the Journal of Diabetes Science and Technology found that approximately 64% of patients using insulin pens reported experiencing at least one adverse event, with 30% reporting pain at the injection site and 15% reporting bruising.

Alternative Delivery Methods and Technological Advancements: The development of alternative insulin delivery methods, such as insulin pumps and inhaled insulin, may limit the growth of the pen needle market. According to the T1D Exchange Clinical Registry, the use of insulin pumps among type 1 diabetes patients in the United States increased from 50% in 2010-2012 to 63% in 2016-2018, potentially reducing the demand for pen needles.

Cost and Reimbursement Issues: The cost of pen needles and variations in reimbursement policies across different regions can limit market growth, especially in developing countries. A report by the American Diabetes Association (ADA) found that the average out-of-pocket cost for diabetes patients using insulin pens was 36% higher compared to those using vials and syringes, with annual costs reaching up to $1,500 more for pen users.

Key Trends

Increasing Focus on Patient Education Programs: Patient education programs represent a significant opportunity in the pen needles market by empowering individuals with diabetes. A study published in the Journal of Diabetes Research found that diabetes self-management education programs resulted in a 0.57% reduction in HbA1c levels among participants. Additionally, the Centers for Disease Control and Prevention (CDC) reported that participation in diabetes self-management education programs increased from 49.6% in 2000 to 53.7% in 2015 among adults with diagnosed diabetes.

Shift Towards Safety-Engineered Pen Needles: The market is seeing a growing trend towards safety-engineered pen needles to reduce the risk of needlestick injuries and improve overall safety for both patients and healthcare workers. According to a report by the World Health Organization (WHO), the use of safety-engineered injection devices, including pen needles, can reduce needlestick injuries by up to 90%. In the United States, the Occupational Safety and Health Administration (OSHA) reported a 32% decrease in needlestick injuries among healthcare workers following the implementation of safety needle legislation.

Development of Smart Pen Needles: The integration of digital technology with pen needles is emerging as a significant trend, allowing for better dose tracking, improved adherence, and data sharing with healthcare providers. A market research report by Verified Market Research projects that the global smart insulin pens market, which includes smart pen needles, is expected to grow at a compound annual growth rate (CAGR) of 12% from 2024 to 2031, reaching a value of USD 332.77 Million by 2031.

Global Pen Needles Market Regional Analysis

Here is a more detailed regional analysis of the global pen needles market:

Europe

Europe is substantially dominating the global pen needles market driven by the robust healthcare infrastructure and access to care.

Europe's robust healthcare infrastructure, stringent regulatory standards, and a well-informed patient population contribute to the widespread adoption of pen needles.

According to the European Commission's State of Health in the EU report, healthcare expenditure in the EU reached 9.9% of GDP in 2019, with an average of 3.7 doctors and 8.2 nurses per 1,000 population, indicating a strong healthcare system capable of supporting advanced medical devices like pen needles.

The increasing incidence of diabetes and other chronic conditions requiring injectable medications drives the demand for pen needles in Europe.

The International Diabetes Federation (IDF) reported that in 2019, approximately 59 million adults (aged 20-79 years) in Europe were living with diabetes, representing 8.9% of the adult population. This number is expected to rise to 68 million by 2045, indicating a growing market for pen needles.

Many European countries have implemented supportive reimbursement policies for diabetes management devices, including pen needles, which encourages their adoption.

A study published in the journal Diabetes Care found that in countries like Germany, France, and the UK, reimbursement rates for diabetes supplies, including pen needles, ranged from 80% to 100%. In Germany, for example, statutory health insurance covers 100% of the cost for prescribed quantities of pen needles for insulin therapy.

Asia Pacific

Asia Pacific is anticipated to witness the fastest growth in the global pen needles market during the forecast period owing to the increasing prevalence of diabetes and the growing patient population.

The Asia Pacific region has seen a significant increase in diabetes prevalence, driving the demand for pen needles. According to the International Diabetes Federation (IDF) Diabetes Atlas 2021: The number of adults (20-79 years) living with diabetes in the Western Pacific region is expected to increase from 206 million in 2021 to 260 million by 2045.

China alone had 140.9 million adults with diabetes in 2021, and this number is projected to reach 174.4 million by 2045. In India, the number of adults with diabetes is expected to increase from 74.2 million in 2021 to 124.9 million by 2045.

Rising healthcare spending in Asia Pacific countries is supporting the growth of the pen needles market. The World Health Organization (WHO) reports: that China's current health expenditure per capita increased from $156 in 2000 to $535 in 2018. In India, the current health expenditure per capita rose from $20 in 2000 to $73 in 2018.

Japan's healthcare spending per capita increased from $2,900 in 2000 to $4,267 in 2018. Many Asian countries have implemented national programs and policies to address the growing diabetes epidemic, indirectly boosting the pen needles market. For example:

The Chinese government launched the "Healthy China 2030" plan, which aims to reduce the incidence of diabetes and improve the management of the condition. India's National Programme for Prevention and Control of Cancer, Diabetes, Cardiovascular Diseases and Stroke (NPCDCS) has been implemented in all states, covering 691 districts as of 2021, according to the Indian Ministry of Health and Family Welfare.

Global Pen Needles Market: Segmentation Analysis

The Global Pen Needles Market is segmented based on Type, Therapy, Application, And Geography.

Pen Needles Market, By Type

• Standard Pen Needles
• Safety Pen Needles

Based on the Type, the Global Pen Needles Market is bifurcated into Standard Pen Needles, and Safety Pen Needles. The standard pen needles segment dominates the global pen needles market, driven by the rising diabetic population and increased awareness about insulin pen usage. These needles are commonly used by individuals with dexterity issues, offering ease of administration for larger daily insulin doses. However, despite their widespread use, concerns over needlestick injuries pose a challenge to their safe application, which may affect demand in the future.

Pen Needles Market, By Therapy

• Insulin
• Glucagon-like Peptide-1 (GLP-1)
• Growth Hormone

Based on the Therapy, the Global Pen Needles Market is bifurcated into Insulin, Glucagon-like Peptide-1 (GLP-1), and Growth Hormone. The insulin segment in the global pen needles market focuses on devices tailored for administering insulin, essential for diabetes management. A key trend is the development of advanced features like ultra-thin needles and painless injection options to enhance patient comfort. Additionally, the availability of various needle lengths and gauges supports personalized insulin therapy, addressing the diverse needs of diabetic patients.

Pen Needles Market, By Application

• Diabetes
• Hormonal Disorders

Based on the Application, the Global Pen Needles Market is bifurcated into Diabetes, and Hormonal Disorders. Diabetes dominates the global pen needles market, driven by the rising prevalence of the disease and increasing awareness of effective diabetes management. The demand for pen needles has surged as they offer convenience and precision in insulin administration, making them indispensable for diabetes patients. This growing reliance on pen needles underscores their essential role in managing the condition, contributing to their widespread adoption in the market.

Pen Needles Market, By Geography

• North America
• Europe
• Asia Pacific
• Rest of the World

Based on Geography, the Global Pen Needles Market is classified into North America, Europe, Asia Pacific, and the Rest of the World. Europe is substantially dominating the global pen needles market driven by the robust healthcare infrastructure and access to care. Europe's robust healthcare infrastructure, stringent regulatory standards, and a well-informed patient population contribute to the widespread adoption of pen needles. According to the European Commission's State of Health in the EU report, healthcare expenditure in the EU reached 9.9% of GDP in 2019, with an average of 3.7 doctors and 8.2 nurses per 1,000 population, indicating a strong healthcare system capable of supporting advanced medical devices like pen needles. The increasing incidence of diabetes and other chronic conditions requiring injectable medications drives the demand for pen needles in Europe.

Key Players

The "Global Pen Needles Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are Becton, Dickinson and Company, Novo Nordisk, Ypsomed, Owen Mumford, HTL-Strefa, B. Braun Melsungen AG, Artsana Group, Terumo Corporation, Allison Medical, Inc., Ulticare.

• This section offers in-depth analysis through a company overview, position analysis, the regional and industrial footprint of the company, and the ACE matrix for insightful competitive analysis. The section also provides an exhaustive analysis of the financial performances of mentioned players in the given market.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Global Pen Needles Market Key Developments

• In September 2020, HTL-STREFA announced the launch of Droplet Micron, a new pen needle with cutting-edge technology for a superior injection experience. Droplet Micron pen needles are 34G x 3.5mm, making them shorter and thinner than conventional ones. Droplet Micron reduces the amount of penetrating force required for injections by up to 50%.
• In January 2020, MedExel Co., Ltd. exported insulin safety pen needles to European and American markets.